Hualan Biological Engineering Inc.

SZSE:002007.SZ

21.66 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 4,379.1975,341.8734,516.9794,436.25,023.2063,699.9423,216.8992,368.1771,934.671,471.7631,243.4881,117.612972.46961.3961,261.6211,220.493475.163351.138352.992361.277320.788252.905172.66124.37
Cost of Revenue 1,688.2411,624.4781,532.8651,386.881,371.2361,296.71,126.597890.031763.512618.94474.351438.56390.135286.255294.111292.837189.432162.312216.114241.2222.6162.887114.29886.145
Gross Profit 2,690.9563,717.3942,984.1143,049.323,651.972,403.2422,090.3021,478.1451,171.158852.823769.137679.052582.326675.141967.51927.657285.73188.825136.878120.07798.18890.01858.36238.225
Gross Profit Ratio 0.6140.6960.6610.6870.7270.650.650.6240.6050.5790.6190.6080.5990.7020.7670.760.6010.5380.3880.3320.3060.3560.3380.307
Reseach & Development Expenses 333.178280.844314.701253.635213.212143.54146.459129.41598.6469.43356.07959.81463.844.20456.138000000000
General & Administrative Expenses 114.73194.38343.09148.06548.80356.05834.07534.94141.88431.96526.7716.82426.66729.07419.945102.00947.75734.80418.14923.30413.59212.7928.8326.645
Selling & Marketing Expenses 738.7271,163.73929.708775.191,078.127520.43537.831267.69968.44320.23247.36725.71677.87163.77821.2625.7067.08524.99325.38636.54333.3129.13411.7558.451
SG&A 853.4581,258.113972.799823.2551,126.93576.488571.906302.64110.32752.19774.13742.541104.53892.85241.205127.71554.84259.79643.53559.84746.90141.92620.58715.096
Other Expenses 124.738-90.879205.202214.307188.971171.912-1.5697.47666.71824.92647.57223.77732.9419.05818.99114.4055.3532.61400-0.261000
Operating Expenses 1,311.3731,619.0041,492.7011,291.1961,529.113891.94792.407572.305351.227245.193232.952187.121248.656214.899154.521130.49156.47360.49943.58659.84946.90141.92620.58715.096
Operating Income 1,379.5822,098.391,424.4631,696.4162,150.5011,615.1991,391.429916.01838.45668.362583.647538.05344.261453.148799.832769.194213.522125.73594.56159.83945.19242.41134.00918.36
Operating Income Ratio 0.3150.3930.3150.3820.4280.4370.4330.3870.4330.4540.4690.4810.3540.4710.6340.630.4490.3580.2680.1660.1410.1680.1970.148
Total Other Income Expenses Net -40.97-20.7483.905-8.171-3.124-4.962-1.5697.45466.47724.16644.17922.99928.7336.85318.84-8.704-4.0312.47-3.777-1.989-6.419-0.655-0.275-0.31
Income Before Tax 1,338.6132,077.6431,428.3681,688.2452,147.3771,610.2371,389.86923.486904.184692.528627.826561.05372.994460.001818.671783.004217.602128.20590.78459.51444.89941.75633.73518.05
Income Before Tax Ratio 0.3060.3890.3160.3810.4270.4350.4320.390.4670.4710.5050.5020.3840.4780.6490.6420.4580.3650.2570.1650.140.1650.1950.145
Income Tax Expense 183.143315.958180.765234.128303.213231.36180.322119.789132.819110.52989.20785.48658.96274.472123.40330.81123.13311.21412.688.2973.5416.2664.8832.6
Net Income 1,087.8511,481.5791,076.2651,298.8971,613.1051,283.4491,139.513820.823780.313589.119538.417475.337299.788370.719612.36608.475187.258120.42979.00152.54341.35835.4928.85115.45
Net Income Ratio 0.2480.2770.2380.2930.3210.3470.3540.3470.4030.40.4330.4250.3080.3860.4850.4990.3940.3430.2240.1450.1290.140.1670.124
EPS 0.60.810.590.710.890.710.630.450.430.320.30.260.170.210.340.340.110.0690.0450.030.0240.0310.0250.013
EPS Diluted 0.590.810.590.710.890.710.630.450.430.320.30.260.170.210.340.340.110.0690.0450.030.0240.0310.0250.013
EBITDA 1,612.5872,390.5331,773.0051,906.4172,334.3451,764.7561,514.7291,062.2141,059.971809.829744.649672.062465.692540.595887.922832.425264.432164.955115.46675.99664.96255.43537.63723.154
EBITDA Ratio 0.3680.4480.3930.430.4650.4770.4710.4490.5480.550.5990.6010.4790.5620.7040.6820.5570.470.3270.210.2030.2190.2180.186